1
|
Burgos JS. Monomania of political strife by Géricault. Lancet Neurol 2023; 22:468-469. [PMID: 37210093 DOI: 10.1016/s1474-4422(23)00159-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2022] [Accepted: 04/17/2023] [Indexed: 05/22/2023]
Affiliation(s)
- Javier S Burgos
- Department of Medicine, Universitat Jaume I, 12071 Castellón de la Plana, Spain.
| |
Collapse
|
2
|
Camacho J, Giménez E, Albert E, Zulaica J, Álvarez‐Rodríguez B, Torres I, Rusu L, Burgos JS, Peiró S, Vanaclocha H, Limón R, Alcaraz MJ, Sánchez‐Payá J, Díez‐Domingo J, Comas I, Gonzáles‐Candelas F, Geller R, Navarro D. Cumulative incidence of SARS-CoV-2 infection in the general population of the Valencian Community (Spain) after the surge of the Omicron BA.1 variant. J Med Virol 2023; 95:e28284. [PMID: 36333837 PMCID: PMC9828341 DOI: 10.1002/jmv.28284] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2022] [Revised: 10/04/2022] [Accepted: 10/31/2022] [Indexed: 11/08/2022]
Abstract
Studies investigating the cumulative incidence of and immune status against SARS-CoV-2 infection provide valuable information for shaping public health decision-making. A cross-sectional study on 935 participants, conducted in the Valencian Community (VC), measuring anti-SARS-CoV-2-receptor binding domain-RBD-total antibodies and anti-Nucleocapsid (N)-IgGs via electrochemiluminescence assays. Quantitation of neutralizing antibodies (NtAb) against ancestral and Omicron BA.1 and BA.2 variants and enumeration of SARS-CoV-2-S specific-IFNγ-producing CD4+ and CD8+ T cells was performed in 100 and 137 participants, respectively. The weighted cumulative incidence was 51.9% (95% confidence interval [CI]: 48.7-55.1) and was inversely related to age. Anti-RBD total antibodies were detected in 97% of participants; vaccinated and SARS-CoV-2-experienced (VAC-ex; n = 442) presented higher levels (p < 0.001) than vaccinated/naïve (VAC-n; n = 472) and nonvaccinated/experienced (UNVAC-ex; n = 63) subjects. Antibody levels correlated inversely with time elapsed since last vaccine dose in VAC-n (Rho, -0.52; p < 0.001) but not in VAC-ex (rho -0.02; p = 0.57). Heterologous booster shots resulted in increased anti-RBD antibody levels compared with homologous schedules in VAC-n, but not in VAC-ex. NtAbs against Omicron BA.1 were detected in 94%, 75%, and 50% of VAC-ex, VAC-n and UNVAC-ex groups, respectively. For Omicron BA.2, the figures were 97%, 84%, and 40%, respectively. SARS-CoV-2-S-reactive IFN-γ T cells were detected in 73%, 75%, and 64% of VAC-ex, VAC-n and UNVAC-ex, respectively. Median frequencies for both T-cell subsets were comparable across groups. In summary, by April 2022, around half of the VC population had been infected with SARS-CoV-2 and, due to extensive vaccination, displayed hybrid immunity.
Collapse
Affiliation(s)
- Jorge Camacho
- Microbiology Service, Clinic University Hospital, INCLIVA Health Research InstituteValenciaSpain
| | - Estela Giménez
- Microbiology Service, Clinic University Hospital, INCLIVA Health Research InstituteValenciaSpain
| | - Eliseo Albert
- Microbiology Service, Clinic University Hospital, INCLIVA Health Research InstituteValenciaSpain
| | - Joao Zulaica
- Institute for Integrative Systems Biology (I2SysBio)University of Valencia‐CSICValenciaSpain
| | | | - Ignacio Torres
- Microbiology Service, Clinic University Hospital, INCLIVA Health Research InstituteValenciaSpain
| | - Luciana Rusu
- Institute for Integrative Systems Biology (I2SysBio)University of Valencia‐CSICValenciaSpain
| | - Javier S. Burgos
- General Directorate of Research and Healthcare Supervision, Department of HealthValencia GovernmentValenciaSpain
| | - Salvador Peiró
- Foundation for the Promotion of Health and Biomedical Research of the Valencian Community (FISABIO)ValenciaSpain
| | - Hermelinda Vanaclocha
- General Directorate of Public Health, Department of HealthValencia GovernmentValenciaSpain
| | - Ramón Limón
- General Directorate of Healthcare. Department of HealthValencian GovernmentValenciaSpain
| | - María Jesús Alcaraz
- Microbiology Service, Clinic University Hospital, INCLIVA Health Research InstituteValenciaSpain
| | - José Sánchez‐Payá
- Preventive Medicine Service, Alicante General and University HospitalAlicanteSpain,Alicante Institute of Health and Biomedical Research (ISABIAL)AlicanteSpain
| | - Javier Díez‐Domingo
- Foundation for the Promotion of Health and Biomedical Research of the Valencian Community (FISABIO)ValenciaSpain
| | - Iñaki Comas
- Biomedicine Institute of Valencia, Spanish Research Council (CSIC)ValenciaSpain,CIBER in Epidemiology and Public Health, Spain; Joint Research Unit “Infection and Public Health” FISABIO‐University of ValenciaValenciaSpain
| | - Fernando Gonzáles‐Candelas
- Institute for Integrative Systems Biology (I2SysBio)University of Valencia‐CSICValenciaSpain,CIBER in Epidemiology and Public Health, Spain; Joint Research Unit “Infection and Public Health” FISABIO‐University of ValenciaValenciaSpain
| | - Ron Geller
- Institute for Integrative Systems Biology (I2SysBio)University of Valencia‐CSICValenciaSpain
| | - David Navarro
- Microbiology Service, Clinic University Hospital, INCLIVA Health Research InstituteValenciaSpain,Department of Microbiology, School of MedicineUniversity of ValenciaValenciaSpain
| | | |
Collapse
|
3
|
Chico-Sánchez P, Gras-Valentí P, Algado-Sellés N, Jiménez-Sepúlveda N, Vanaclocha H, Peiró S, Burgos JS, Berenguer A, Navarro D, Sánchez-Payá J. The effectiveness of mRNA vaccines to prevent SARS-CoV-2 infection and hospitalisation for COVID-19 according to the time elapsed since their administration in health professionals in the Valencian Autonomous Community (Spain). Prev Med 2022; 163:107237. [PMID: 36057393 PMCID: PMC9433063 DOI: 10.1016/j.ypmed.2022.107237] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/14/2022] [Revised: 07/29/2022] [Accepted: 08/28/2022] [Indexed: 11/30/2022]
Abstract
The objective was to understand the effectiveness of the BNT162b2 and mRNA-1273 vaccines against SARS-CoV-2 in health professionals(HPs) in the Valencian Autonomous Community(Spain) who had completed a full vaccination regimen, both in terms of preventing infections and avoiding hospitalisations, according to the time elapsed since the vaccine administration. Case-controlled study with negative test results. HPs who had undergone at least one PCR or antigen(Ag) active infection diagnostic test(AIDT) to rule out SARS-CoV-2 infection between 25 January and 18 July 2021 were included. HPs with positive AIDT result were considered as cases and those with a negative result controls. Adjusted vaccine effectiveness(VEa) to prevent SARS-CoV-2 infection and its 95% confidence interval(95% CI) were calculated using the formula VEa = (1 - OR) × 100. The VEa for the prevention of SARS-CoV-2 infection 12 to 120 days after completing the full two-dose vaccine regimen was 91.6%(95%CI[89.6%,93.2%]) for the BNT162b2 vaccine and 95.2%(95%CI[88.3%,98.1%]) for the mRNA-1273 vaccine. After 120 days the VEa was 71.5%(95%CI[67.0%,75.5%]) for the BNT162b2 vaccine and 88.3%(95%CI[75.7,94.4%]) for the mRNA-1273 vaccine. The VEa for prevention of hospitalisation for COVID-19 for the complete two-dose regimen of mRNA vaccines (BNT162b2 and mRNA-1273) was 96.8%(95%CI[76.1%,99.6%]). The administration of the complete regimen of the BNT162b2 and mRNA-1273 vaccine against SARS-CoV-2 was highly effective for the prevention of COVID-19 cases in HPs when 12 to 120 days had elapsed since the second dose. However, said effectiveness decreased as time from the vaccine administration elapsed, although it was maintained for the prevention of hospitalisation of HPs.
Collapse
Affiliation(s)
- Pablo Chico-Sánchez
- Epidemiology Unit, Preventive Medicine Service, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain
| | - Paula Gras-Valentí
- Epidemiology Unit, Preventive Medicine Service, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain
| | - Natividad Algado-Sellés
- Epidemiology Unit, Preventive Medicine Service, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain
| | - Natali Jiménez-Sepúlveda
- Epidemiology Unit, Preventive Medicine Service, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain
| | | | - Salvador Peiró
- Foundation for the promotion of health and biomedical research of the Valencian Community (FISABIO), Valencia, Spain
| | | | | | - David Navarro
- Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain; Department of Microbiology, School of Medicine, University of Valencia, Valencia, Spain
| | - José Sánchez-Payá
- Epidemiology Unit, Preventive Medicine Service, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain.
| | | |
Collapse
|
4
|
Burgos JS. Monomania of drunkenness by Géricault. Lancet Neurol 2022; 21:774-775. [DOI: 10.1016/s1474-4422(22)00304-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2022] [Accepted: 07/15/2022] [Indexed: 10/15/2022]
|
5
|
Sánchez-Saez F, Peiró S, Cuenca L, Vanaclocha H, Limón R, Salas D, Burgos JS, Sánchez-Payá J, Meneu R, Díez J, García-Sempere A, Navarro IH, Rodríguez-Bernal C, Sanfélix-Gimeno G, Navarro D. Side effects during the week after first dose vaccination with four Covid-19 vaccines. Results of the ProVaVac Survey Study with 13,837 people in Spain. Vaccine 2022; 40:5942-5949. [PMID: 36068110 PMCID: PMC9420721 DOI: 10.1016/j.vaccine.2022.08.028] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2022] [Revised: 07/12/2022] [Accepted: 08/15/2022] [Indexed: 12/23/2022]
Abstract
Background In 2021, four vaccines against Covid-19 (BNT162b2, mRNA-1273, ChAdOx1nCoV-19, and JNJ-78436735) were employed in the region of Valencia, Spain. We conducted a survey to identify real-world, self-reported frequency and severity of side effects during the week after vaccination. Methods Survey data was obtained from April 19, 2021, to October 6, 2021, at three different moments in time: day one, day three and day seven after vaccination. Answers were linked to individual-level, personal and clinical information. Respondents were stratified by the vaccine they received and reported effects were presented over time and stratified by severity. We compared our results per vaccine with the frequencies stated in each Summary of Product Characteristics (SmPC). We used binomial logistic models to identify associations between respondent characteristics and side effects. Results No symptoms were reported by 1,986 respondents (14.35 %), 6,254 informed exclusively mild symptoms (45.20 %), 3,444 up to moderate symptoms (24.89 %), and 2,153 people (15.56 %) notified also severe symptoms. Among the latter, the more frequent were extreme tiredness (7.0 %), and nausea or vomiting (7.1 %). The reported frequency of facial paralysis (0.4 %) was much higher than reflected in SmPCs. Female sex, younger age, previous positive Active Infection Diagnostic Test, chronicity, and vaccination with other than the BNT162b2 vaccine were associated to an increased risk of side effects (p < 0.001). Conclusions Side effects after vaccination are common in the real-world. However, they are principally mild, and their frequency declines after a few days. Providing patients with dependable, beforehand information about side effects may improve outcomes and reinforce vaccination programs.
Collapse
Affiliation(s)
- Francisco Sánchez-Saez
- Foundation for the Promotion of Health and Biomedical Research of the Valencia Community (FISABIO), Valencia, Spain
| | - Salvador Peiró
- Foundation for the Promotion of Health and Biomedical Research of the Valencia Community (FISABIO), Valencia, Spain
| | - Llanos Cuenca
- General Directorate for Planning, Technological Efficiency and Patient Care, Department of Health, Valencia Government, Valencia, Spain; Universitat Politècnica de Valencia, UPV
| | - Hermelinda Vanaclocha
- General Directorate of Public Health, Department of Health, Valencia Government, Valencia, Spain
| | - Ramón Limón
- General Directorate of Healthcare, Department of Health, Valencia Government, Valencia, Spain
| | - Dolores Salas
- General Directorate of Public Health, Department of Health, Valencia Government, Valencia, Spain
| | - Javier S Burgos
- General Directorate of Research and Healthcare Supervision, Department of Health, Valencia Government, Valencia, Spain
| | - José Sánchez-Payá
- Preventive Medicine Service, Alicante General and University Hospital, Alicante, Spain; Alicante Institute of Health and Biomedical Research (ISABIAL), Alicante, Spain
| | - Ricard Meneu
- General Directorate of Research and Healthcare Supervision, Department of Health, Valencia Government, Valencia, Spain
| | - Javier Díez
- Foundation for the Promotion of Health and Biomedical Research of the Valencia Community (FISABIO), Valencia, Spain
| | - Aníbal García-Sempere
- Foundation for the Promotion of Health and Biomedical Research of the Valencia Community (FISABIO), Valencia, Spain.
| | - Isabel Hurtado Navarro
- Foundation for the Promotion of Health and Biomedical Research of the Valencia Community (FISABIO), Valencia, Spain
| | - Clara Rodríguez-Bernal
- Foundation for the Promotion of Health and Biomedical Research of the Valencia Community (FISABIO), Valencia, Spain
| | - Gabriel Sanfélix-Gimeno
- Foundation for the Promotion of Health and Biomedical Research of the Valencia Community (FISABIO), Valencia, Spain
| | - David Navarro
- Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain; Department of Microbiology, School of Medicine, University of Valencia, Valencia, Spain
| |
Collapse
|
6
|
Torres I, Giménez E, Albert E, Zulaica J, Álvarez-Rodríguez B, Burgos JS, Peiró S, Limón R, Vanaclocha H, Rodado C, Botija P, Sifre A, Tur B, Lozano RA, Orosa I, Vicente-Ruiz M, Carrión RJ, Clari MÁ, Sánchez-Payá J, Díez-Domingo J, Comas I, González-Candelas F, Geller R, Navarro D. SARS-CoV-2 Omicron BA.1 variant breakthrough infections in nursing home residents after an homologous third dose of the Comirnaty® COVID-19 vaccine: Looking for correlates of protection. J Med Virol 2022; 94:4216-4223. [PMID: 35585782 PMCID: PMC9348298 DOI: 10.1002/jmv.27867] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2022] [Revised: 05/10/2022] [Accepted: 05/15/2022] [Indexed: 11/09/2022]
Abstract
OBJECTIVES We investigated whether peripheral blood levels of SARS-CoV-2 Spike (S) receptor binding domain antibodies (anti-RBD), neutralizing antibodies targeting Omicron S (NtAb), and S-reactive-IFNγ-producing CD4+ and CD8+ T cells measured after an homologous booster dose (3D) with the Comirnaty® vaccine were associated with the likelihood of subsequent breakthrough infections due to the Omicron variant. METHODS Observational study including 146 nursing home residents (median age, 80 years; range, 66-99; 109 female) evaluated for an immunological response after 3D (at a median of 16 days). Anti-RBD total antibodies were measured by chemiluminescent immunoassay. NtAb were quantified by an Omicron S pseudotyped virus neutralization assay. SARS-CoV-2-S specific-IFNγ-producing CD4+ and CD8+ T cells were was enumerated by whole-blood flow cytometry for intracellular cytokine staining. RESULTS In total, 33/146 participants contracted breakthrough Omicron infection (symptomatic in 30/33) within 4 months after 3D. Anti-RBD antibody levels were comparable in infected and uninfected participants (21,123 BAU/ml vs. 24,723 BAU/ml; P=0.34). Likewise, NtAb titers (reciprocal IC50 titer, 157 vs. 95; P=0.32) and frequency of virus-reactive CD4+ (P=0.82) and CD8+ (P=0.91) T cells were similar across participant in both groups. Anti-RBD antibody levels and NtAb titers estimated at around the time of infection were also comparable (3,445 BAU/ml vs. 4,345 BAU/ml; P=0.59 and 188.5 vs. 88.9; P=0.70, respectively). Having detectable NtAb against Omicron or SARS-CoV-2-S-reactive-IFNγ-producing CD4+ or CD8+ T cells after 3D was not correlated with increased protection from breakthrough infection (OR, 1.50; P=0.54; 0.0; P=0.99 and 3.70; P=0.23, respectively). CONCLUSION None of the immune parameters evaluated herein, including NtAb titers against the Omicron variant, may reliably predict at the individual level the risk of contracting COVID-19 due to Omicron variant in nursing home residents. This article is protected by copyright. All rights reserved.
Collapse
Affiliation(s)
- Ignacio Torres
- Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain
| | - Estela Giménez
- Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain
| | - Eliseo Albert
- Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain
| | - Joao Zulaica
- Institute for Integrative Systems Biology (I2SysBio), Universitat de Valencia-CSIC, 46980, Valencia, Spain
| | - Beatriz Álvarez-Rodríguez
- Institute for Integrative Systems Biology (I2SysBio), Universitat de Valencia-CSIC, 46980, Valencia, Spain
| | - Javier S Burgos
- General Directorate of Research and Healthcare Supervision, Department of Health, Valencia Government, Valencia, Spain
| | - Salvador Peiró
- Foundation for the promotion of health and biomedical research of the Valencian Community (FISABIO), Valencia, Spain
| | - Ramón Limón
- General Directorate of Healthcare. Department of Health, Valencian Government, Valencia, Spain
| | - Hermelinda Vanaclocha
- General Directorate of Public Health, Department of Health, Valencia Government, Valencia, Spain
| | - Celia Rodado
- Comisión Departamental de control de Residencias. Departamento de Salud València Clínico Malvarrosa
| | - Pilar Botija
- Dirección de Atención Primaria, Departamento de Salud Clínico-Malvarrosa, Hospital Clínico Universitario de Valencia, Valencia, Spain
| | | | - Borja Tur
- Centro de Salud Pública, Gandía, Spain
| | | | | | | | - Ramón J Carrión
- dirección De Atención Primaria, Departamento De Salud Arnau-Lliria, Valencia, Spain
| | - Mª Ángeles Clari
- Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain
| | - José Sánchez-Payá
- Preventive Medicine Service, Alicante General and University Hospital, Alicante, Spain.,Alicante Institute of Health and Biomedical Research (ISABIAL), Alicante, Spain
| | - Javier Díez-Domingo
- Foundation for the promotion of health and biomedical research of the Valencian Community (FISABIO), Valencia, Spain
| | - Iñaki Comas
- Biomedicine Institute of Valencia, Spanish Research Council (CSIC).,CIBER in Epidemiology and Public Health, Spain; Joint Research Unit "Infection and Public Health", FISABIO-University of Valencia, Valencia, Spain
| | - Fernando González-Candelas
- Institute for Integrative Systems Biology (I2SysBio), Universitat de Valencia-CSIC, 46980, Valencia, Spain.,CIBER in Epidemiology and Public Health, Spain; Joint Research Unit "Infection and Public Health", FISABIO-University of Valencia, Valencia, Spain
| | - Ron Geller
- Institute for Integrative Systems Biology (I2SysBio), Universitat de Valencia-CSIC, 46980, Valencia, Spain
| | - David Navarro
- Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.,Department of Microbiology, School of Medicine, University of Valencia, Valencia, Spain
| | | |
Collapse
|
7
|
Torres I, Bellido-Blasco JB, Gimeno C, Burgos JS, Albert E, Moya-Malo R, Gascó-Laborda JC, Tornero A, Soriano J, Meseguer-Ferrer N, Martínez-Serrano M, Ortíz-Rambla J, Buj H, Hernández N, Peiró S, Salas D, Limón R, Vanaclocha H, Sánchez-Payá J, Díez-Domingo J, Comas I, González-Candelas F, Navarro D. SARS-CoV-2 Delta-variant breakthrough infections in nursing home residents at mid-term after Comirnaty® COVID-19 vaccination. J Med Virol 2022; 94:3776-3782. [PMID: 35445415 PMCID: PMC9088586 DOI: 10.1002/jmv.27799] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2022] [Revised: 03/28/2022] [Accepted: 04/19/2022] [Indexed: 11/10/2022]
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) Delta variant breakthrough infections in nursing home residents following vaccination with Comirnaty® COVID‐19 vaccine were characterized. In total, 201 participants (median age, 87 years; range, 64–100; 133 female) from two nursing homes in the Valencian community (Spain) were included. SARS‐CoV‐2‐Spike (S) antibody responses were determined by a lateral flow immunocromatography (LFIC) assay and by quantitative electrochemiluminescent assay in LFIC‐negative participants. SARS‐CoV‐2‐S‐IFNγ T cells were enumerated by flow cytometry in 10 participants. Nasopharyngeal SARS‐CoV‐2 RNA loads were quantified by real‐time polymerase chain reaction assays. Vaccine breakthrough COVID‐19 due to the Delta variant occurred in 39 residents (median age, 87 years; range, 69–96; 31 female) at a median of 6.5 months after vaccination (nine requiring hospitalization). Breakthrough infections occurred at a higher rate (p < 0.0001) in residents who had not been previously infected with SARS‐CoV‐2 (naïve) (33/108; 18%) than in those with prior diagnosis of SARS‐CoV‐2 infection (experienced) (6/93; 6.4%), and were more likely (p < 0.0001) to develop in residents who tested negative by LFIC (20/49) at 3 months after vaccination as compared to their LFIC‐positive counterparts (19/142). Among LFIC‐negative residents, a trend towards lower plasma anti‐RBD antibody levels was noticed in those developing breakthrough infection (p = 0.16). SARS‐CoV‐2 RNA loads in nasopharyngeal specimens were lower in SARS‐CoV‐2‐experienced residents (p < 0.001) and in those testing positive by LFIC (p = 0.13). The frequency of SARS‐CoV‐2‐S‐reactive T cells at 3 months was similar in LFIC‐negative residents with (n = 7) or without (n = 3) breakthrough infection. Prior history of SARS‐CoV‐2 infection and detection of S‐reactive antibodies by LFIC at 3 months is associated with a lower risk of Delta‐variant breakthrough infection in nursing home residents at midterm after Comirnaty® COVID‐19 vaccination.
Collapse
Affiliation(s)
- Ignacio Torres
- Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain
| | - Juan B Bellido-Blasco
- Sección de Epidemiología, Centro de Salud Pública de Castellón, Valencia, Spain.,Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Valencia, Spain.,Universitat Jaume I (UJI), Castelló, Spain
| | - Concepción Gimeno
- Microbiology Service, Consorcio Hospital General Universitario de Valencia, Valencia, Spain.,Department of Microbiology, School of Medicine, University of Valencia, Valencia, Spain
| | - Javier S Burgos
- General Directorate of Research and Healthcare Supervision, Department of Health, Valencia Government, Valencia, Spain
| | - Eliseo Albert
- Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain
| | | | | | - Ana Tornero
- Primary Health Directory, Consorcio Hospital General Universitario de Valencia, Valencia, Spain
| | - Josefa Soriano
- Primary Health Directory, Consorcio Hospital General Universitario de Valencia, Valencia, Spain
| | | | - María Martínez-Serrano
- Microbiology Service, Consorcio Hospital General Universitario de Valencia, Valencia, Spain
| | - Javier Ortíz-Rambla
- Unidad de Hospitalización Domiciliaria del Departamento de Salud de la Plana, Castellón, Spain
| | - Helena Buj
- Laboratory Service, Hospital de la Plana, Vila-Real, Castellón, Spain
| | - Noelia Hernández
- Laboratory Service, Hospital de la Plana, Vila-Real, Castellón, Spain
| | - Salvador Peiró
- Foundation for the promotion of Health and Biomedical Research of the Valencian Community (FISABIO), Valencia, Spain
| | - Dolores Salas
- Foundation for the promotion of Health and Biomedical Research of the Valencian Community (FISABIO), Valencia, Spain.,General Directorate of Public Health, Department of Health, Valencia Government, Valencia, Spain
| | - Ramón Limón
- General Directorate of Healthcare. Department of Health, Valencian Government, Valencia, Spain
| | - Hermelinda Vanaclocha
- General Directorate of Public Health, Department of Health, Valencia Government, Valencia, Spain
| | - José Sánchez-Payá
- Preventive Medicine Service, Alicante General and University Hospital, Alicante, Spain.,Alicante Institute of Health and Biomedical Research (ISABIAL), Alicante, Spain
| | - Javier Díez-Domingo
- Foundation for the promotion of Health and Biomedical Research of the Valencian Community (FISABIO), Valencia, Spain
| | - Iñaki Comas
- Biomedicine Institute of Valencia, Spanish Research Council (CSIC).,CIBER in Epidemiology and Public Health, Spain
| | - Fernando González-Candelas
- CIBER in Epidemiology and Public Health, Spain.,Joint Research Unit "Infection and Public Health" FISABIO-University of Valencia, Valencia, Spain.,Institute for Integrative Systems Biology (I2SysBio), CSIC-University of Valencia, Valencia, Spain
| | - David Navarro
- Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.,Department of Microbiology, School of Medicine, University of Valencia, Valencia, Spain
| | | |
Collapse
|
8
|
Giménez E, Albert E, Zulaica J, Torres I, Rusu L, Rodríguez Moreno A, Burgos JS, Peiró S, Salas D, Vanaclocha H, Limón R, Alcaraz MJ, Sánchez-Payá J, Díez-Domingo J, Comas I, Gonzáles-Candelas F, Geller R, Navarro D. Severe Acute Respiratory Syndrome Coronavirus 2 Adaptive Immunity in Nursing Home Residents Following a Third Dose of the Comirnaty Coronavirus Disease 2019 Vaccine. Clin Infect Dis 2022; 75:e865-e868. [PMID: 35314856 PMCID: PMC9129117 DOI: 10.1093/cid/ciac223] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2021] [Indexed: 01/19/2023] Open
Abstract
A third Comirnaty vaccine dose increased severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor-binding domain antibody levels (median, 93-fold) and neutralizing antibody titers against Wuhan-Hu-1 (median, 57-fold), Beta (me 22-fold), Delta, (median, 43-fold), and Omicron (median, 8-fold) variants, but had less impact on S-reactive T-cell immunity in nursing home residents.
Collapse
Affiliation(s)
- Estela Giménez
- Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain
| | - Eliseo Albert
- Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain
| | - Joao Zulaica
- Institute for Integrative Systems Biology (I2SysBio), Universitat de Valencia-CSIC, Valencia, Spain
| | - Ignacio Torres
- Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain
| | - Luciana Rusu
- Institute for Integrative Systems Biology (I2SysBio), Universitat de Valencia-CSIC, Valencia, Spain
| | - Alicia Rodríguez Moreno
- Institute for Integrative Systems Biology (I2SysBio), Universitat de Valencia-CSIC, Valencia, Spain
| | - Javier S Burgos
- General Directorate of Research and Healthcare Supervision, Department of Health, Valencia Government, Valencia, Spain
| | - Salvador Peiró
- Foundation for the promotion of health and biomedical research of the Valencian Community (FISABIO), Valencia, Spain
| | - Dolores Salas
- Foundation for the promotion of health and biomedical research of the Valencian Community (FISABIO), Valencia, Spain,General Directorate of Public Health, Department of Health, Valencia Government, Valencia, Spain
| | - Hermelinda Vanaclocha
- General Directorate of Public Health, Department of Health, Valencia Government, Valencia, Spain
| | - Ramón Limón
- General Directorate of Healthcare. Department of Health, Valencian Government, Valencia, Spain
| | - María Jesús Alcaraz
- Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain
| | - José Sánchez-Payá
- Preventive Medicine Service, Alicante General and University Hospital, Alicante, Spain,Alicante Institute of Health and Biomedical Research (ISABIAL), Alicante, Spain
| | - Javier Díez-Domingo
- Foundation for the promotion of health and biomedical research of the Valencian Community (FISABIO), Valencia, Spain
| | - Iñaki Comas
- Biomedicine Institute of Valencia, Spanish Research Council (CSIC), Valencia, Spain,CIBER in Epidemiology and Public Health, Spain; Joint Research Unit "Infection and Public Health" FISABIO-University of Valencia, Valencia, Spain
| | - Fernando Gonzáles-Candelas
- Institute for Integrative Systems Biology (I2SysBio), Universitat de Valencia-CSIC, Valencia, Spain,CIBER in Epidemiology and Public Health, Spain; Joint Research Unit "Infection and Public Health" FISABIO-University of Valencia, Valencia, Spain
| | - Ron Geller
- Institute for Integrative Systems Biology (I2SysBio), Universitat de Valencia-CSIC, Valencia, Spain
| | - David Navarro
- Correspondence: David Navarro, Microbiology Service, Hospital Clínico Universitario, Instituto de Investigación INCLIVA. Av. Blasco Ibáñez 17, 46010 Valencia, Spain.
| | | |
Collapse
|
9
|
Giménez E, Albert E, Burgos JS, Peiró S, Salas D, Vanaclocha H, Limón R, Alcaraz MJ, Sánchez-Payá J, Díez-Domingo J, Comas I, Gonzáles-Candelas F, Navarro D. SARS-CoV-2 adaptive immunity in nursing home residents up to eight months after two doses of the Comirnaty® COVID-19 vaccine. J Infect 2022; 84:834-872. [PMID: 35245583 PMCID: PMC8889892 DOI: 10.1016/j.jinf.2022.02.035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2022] [Accepted: 02/27/2022] [Indexed: 11/16/2022]
Abstract
Burgos JS (General Directorate of Research and Healthcare Supervision, Department of Health, Valencia Government, Valencia, Spain); Meneu de Guillerna R (Vice-President Foundation Research Institute in Public Services, Valencia, Spain); Vanaclocha Luna H (General Directorate of Public Health, Department of Health, Valencia Government, Valencia, Spain); Burks DJ (The Prince Felipe Research Center-CIPF-, Valencia, Spain; Cervantes A (INCLIVA Health Research Institute, Valencia, Spain); Comas I (Biomedicine Institute of Valencia, Spanish Research Council (CSIC); Díez-Domingo J (Foundation for the promotion of health and biomedical research of the Valencian Community-FISABIO-, Valencia, Spain); Peiro S (Foundation for the promotion of health and biomedical research of the Valencian Community-FISABIO-, Valencia, Spain); González-Candelas F (CIBER in Epidemiology and Public Health, Spain; Joint Research Unit "Infection and Public Health" FISABIO-University of Valencia, Valencia, Spain; Institute for Integrative Systems Biology (I2SysBio), CSIC-University of Valencia, Valencia, Spain); Ferrer Albiach C (Fundación Hospital Provincial de Castelló); Hernández-Aguado I (University Miguel Hernández, Alicante, Spain); Oliver Ramírez N (DataPop Alliance); Sánchez-Payá J (Preventive Medicine Service, Alicante General and University Hospital, Alicante, Spain; Alicante Institute of Health and Biomedical Research (ISABIAL), Alicante, Spain; Vento Torres M (Instituto de Investigación Sanitaria La Fe); Zapater Latorre E (Fundación Hospital General Universitario de València); Navarro D (Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain;Department of Microbiology, School of Medicine, University of Valencia, Valencia, Spain).
Collapse
Affiliation(s)
- Estela Giménez
- Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain
| | - Eliseo Albert
- Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain
| | - Javier S Burgos
- General Directorate of Research and Healthcare Supervision, Department of Health, Valencia Government, Valencia, Spain
| | - Salvador Peiró
- Foundation for the promotion of health and biomedical research of the Valencian Community (FISABIO), Valencia, Spain
| | - Dolores Salas
- Foundation for the promotion of health and biomedical research of the Valencian Community (FISABIO), Valencia, Spain.; General Directorate of Public Health, Department of Health, Valencia Government, Valencia, Spain
| | - Hermelinda Vanaclocha
- General Directorate of Public Health, Department of Health, Valencia Government, Valencia, Spain
| | - Ramón Limón
- General Directorate of Healthcare. Department of Health, Valencian Government, Valencia, Spain
| | - María Jesús Alcaraz
- Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain
| | - José Sánchez-Payá
- Preventive Medicine Service, Alicante General and University Hospital, Alicante, Spain.; Alicante Institute of Health and Biomedical Research (ISABIAL), Alicante, Spain
| | - Javier Díez-Domingo
- Foundation for the promotion of health and biomedical research of the Valencian Community (FISABIO), Valencia, Spain
| | - Iñaki Comas
- Biomedicine Institute of Valencia, Spanish Research Council (CSIC)
| | - Fernando Gonzáles-Candelas
- CIBER in Epidemiology and Public Health, Spain; Joint Research Unit "Infection and Public Health" FISABIO-University of Valencia, Valencia, Spain; Institute for Integrative Systems Biology (I2SysBio), CSIC-University of Valencia, Valencia, Spain
| | - David Navarro
- Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.; Department of Microbiology, School of Medicine, University of Valencia, Valencia, Spain..
| |
Collapse
|
10
|
Albert E, Burgos JS, Peiró S, Salas D, Vanaclocha H, Giménez E, Limón R, Alcaraz MJ, Sánchez-Payá J, Díez-Domingo J, Navarro D. Immunological response against SARS-CoV-2 following full-dose administration of Comirnaty® COVID-19 vaccine in nursing home residents. Clin Microbiol Infect 2022; 28:279-284. [PMID: 34619398 PMCID: PMC8490129 DOI: 10.1016/j.cmi.2021.09.031] [Citation(s) in RCA: 10] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2021] [Revised: 08/26/2021] [Accepted: 09/25/2021] [Indexed: 11/03/2022]
Abstract
OBJECTIVES The current study was aimed at examining SARS-CoV-2 immune responses following two doses of Comirnaty® COVID-19 vaccine among elderly people in nursing homes. METHODS A prospective cohort study in a representative sample from nursing homes in Valencia (n = 881; males: 271, females 610; median age, 86 years) recruited residents using a random one-stage cluster sampling approach. A lateral flow immunochromatography device (LFIC) (OnSite COVID-19 IgG/IgM Rapid Test; CTK BIOTECH, Poway, CA, USA) was used as the front-line test for detecting SARS-CoV-2-Spike (S)-specific antibodies in whole blood obtained using a fingerstick. Residents returning negative LFIC results underwent venipuncture and testing for presence of SARS-CoV-2-S-reactive antibodies and T cells using the Roche Elecsys® Anti-SARS-CoV-2 S (Roche Diagnostics, Pleasanton, CA, USA), the LIAISON® SARS-CoV-2 TrimericS IgG assay (Diasorin S.p.A, Saluggia, Italy) and by flow cytometry, respectively. RESULTS The SARS-CoV-2-S antibody detection rate in nursing home residents was 99.6% (283/284) and 98.3% (587/597) for SARS-CoV-2 recovered and naïve residents, respectively, within a median of 99 days (range 17-125 days) after full vaccination. Three out of five residents lacking SARS-CoV-2-S antibodies had detectable S-reactive CD8+ and/or CD4+ T cells. In addition, 50/50 and 40/50 participants with detectable SARS-CoV-2 antibodies also had SARS-CoV-2-S-reactive interferon-γ-producing CD4+ and CD8+ T cells, respectively. DISCUSSION The Comirnaty® COVID-19 vaccine is highly immunogenic in nursing home residents.
Collapse
Affiliation(s)
- Eliseo Albert
- Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain
| | - Javier S Burgos
- General Directorate of Research and Healthcare Supervision, Department of Health, Valencia Government, Valencia, Spain
| | - Salvador Peiró
- Foundation for the Promotion of Health and Biomedical Research of the Valencian Community (FISABIO), Valencia, Spain
| | - Dolores Salas
- Foundation for the Promotion of Health and Biomedical Research of the Valencian Community (FISABIO), Valencia, Spain; General Directorate of Public Health, Department of Health, Valencia Government, Valencia, Spain
| | - Hermelinda Vanaclocha
- General Directorate of Public Health, Department of Health, Valencia Government, Valencia, Spain
| | - Estela Giménez
- Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain
| | - Ramón Limón
- General Directorate of Healthcare. Department of Health, Valencia Government, Valencia, Spain
| | - María Jesús Alcaraz
- Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain
| | - José Sánchez-Payá
- Preventive Medicine Service, Alicante General and University Hospital, Alicante, Spain; Alicante Institute of Health and Biomedical Research (ISABIAL), Alicante, Spain
| | - Javier Díez-Domingo
- Foundation for the Promotion of Health and Biomedical Research of the Valencian Community (FISABIO), Valencia, Spain
| | - David Navarro
- Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain; Department of Microbiology, School of Medicine, University of Valencia, Valencia, Spain.
| |
Collapse
|
11
|
Affiliation(s)
- Javier S Burgos
- Dirección General de Investigación y Alta Inspección Sanitaria, Conselleria de Sanitat Universal i Salut Pública, 46010 Valencia, Spain.
| |
Collapse
|
12
|
Gil-Montoya JA, Barrios R, Santana S, Sanchez-Lara I, Pardo CC, Fornieles-Rubio F, Montes J, Ramírez C, González-Moles MA, Burgos JS. Association Between Periodontitis and Amyloid β Peptide in Elderly People With and Without Cognitive Impairment. J Periodontol 2017; 88:1051-1058. [PMID: 28598287 DOI: 10.1902/jop.2017.170071] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Abstract
BACKGROUND Evidence that periodontal disease is a possible risk factor for cognitive impairment may be explained by the inflammatory hypothesis. The aim of this study is to determine whether periodontitis is related to the amyloid β (Aβ) load in blood and the role of any such relationship in the association between Aβ and cognitive impairment. METHODS A case-control study was performed in elderly people diagnosed with cognitive impairment with or without dementia (cases group) and cognitively healthy elderly people (control group); data were collected on the medical and dental history of participants, and blood samples were drawn to determine Aβ levels using enzyme-linked immunosorbent assay. RESULTS The study included 166 patients and 122 control participants. Higher blood Aβ1-42 levels (P = 0.01) and higher Aβ42:40 ratio (P = 0.06) were observed in participants with severe attachment loss than in other participants. Periodontitis was a significant interaction variable, given that the association between Aβ1-42 and Aβ1-40 and cognitive impairment was only observed in patients with severe periodontitis. According to these data, periodontitis may be a modulating variable of the association between Aβ and cognitive impairment. CONCLUSIONS Plasma Aβ1-42 levels are higher in individuals who have severe periodontal disease. The presence of periodontitis may modify the association between Aβ and cognitive impairment.
Collapse
Affiliation(s)
| | - Rocío Barrios
- School of Dentistry, Granada Biohealth Research Institute, Granada, Spain
| | - Soraya Santana
- Neuro Biolabs SL, Health Science Technological Park, Granada, Spain
| | - Inés Sanchez-Lara
- School of Dentistry, Granada Biohealth Research Institute, Granada, Spain
| | | | | | | | - Carlos Ramírez
- Neuro Biolabs SL, Health Science Technological Park, Granada, Spain
| | | | - Javier S Burgos
- Neuro Biolabs SL, Health Science Technological Park, Granada, Spain
| |
Collapse
|
13
|
Albasanz JL, Santana S, Guzman-Sanchez F, León D, Burgos JS, Martín M. 2-Methyl-6-(phenylethynyl)pyridine Hydrochloride Modulates Metabotropic Glutamate 5 Receptors Endogenously Expressed in Zebrafish Brain. ACS Chem Neurosci 2016; 7:1690-1697. [PMID: 27635438 DOI: 10.1021/acschemneuro.6b00213] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022] Open
Abstract
Due to phylogenetic proximity to the human, zebrafish has been recognized as a reliable model to study Alzheimer's disease (AD) and other central nervous system disorders. Furthermore, metabotropic glutamate receptors have been previously reported to be impaired in brain from AD patients. Metabotropic glutamate 5 (mGlu5) receptors are G-protein coupled receptors proposed as potential targets for therapy of different neurodegenerative disorders. Thus, MPEP (2-methyl-6-(phenylethynyl)pyridine hydrochloride), a selective noncompetitive mGlu5 receptor antagonist, has been suggested for pharmacological treatment of AD. The aim of the present work was to quantify mGlu5 receptors in brain from zebrafish and to study the possible modulation of these receptors by MPEP treatment. To this end, radioligand binding assay and open field test were used. Results showed a slightly higher presence of mGlu5 receptors in brain from male than in that from female zebrafish. However, a significant increase of mGlu5 receptor in male without variation in female was observed after MPEP treatment. This gender specific response was also observed in locomotor behavior, being significantly decreased only in male zebrafish. These results confirm the presence of mGlu5 receptors in brain from zebrafish and their gender specific modulation by selective antagonist treatment and suggest a role of these receptors on locomotor activity, which is affected in many disorders. In addition, our data point to zebrafish as a useful model to study mGlu receptor function in both healthy and pathological conditions.
Collapse
Affiliation(s)
- José Luis Albasanz
- Departamento de Química Inorgánica,
Orgánica y Bioquímica, Facultad de Medicina de Ciudad
Real/Facultad de Ciencias y Tecnologías Químicas, Universidad de Castilla-La Mancha, Centro Regional de Investigaciones Biomédicas (CRIB), Avenida Camilo José Cela 10, 13071 Ciudad Real, Spain
| | | | | | - David León
- Departamento de Química Inorgánica,
Orgánica y Bioquímica, Facultad de Medicina de Ciudad
Real/Facultad de Ciencias y Tecnologías Químicas, Universidad de Castilla-La Mancha, Centro Regional de Investigaciones Biomédicas (CRIB), Avenida Camilo José Cela 10, 13071 Ciudad Real, Spain
| | | | - Mairena Martín
- Departamento de Química Inorgánica,
Orgánica y Bioquímica, Facultad de Medicina de Ciudad
Real/Facultad de Ciencias y Tecnologías Químicas, Universidad de Castilla-La Mancha, Centro Regional de Investigaciones Biomédicas (CRIB), Avenida Camilo José Cela 10, 13071 Ciudad Real, Spain
| |
Collapse
|
14
|
Gil-Montoya JA, Sanchez-Lara I, Carnero-Pardo C, Fornieles F, Montes J, Vilchez R, Burgos JS, Gonzalez-Moles MA, Barrios R, Bravo M. Is periodontitis a risk factor for cognitive impairment and dementia? A case-control study. J Periodontol 2014; 86:244-53. [PMID: 25345338 DOI: 10.1902/jop.2014.140340] [Citation(s) in RCA: 63] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Abstract
BACKGROUND Dementia is a multi-etiologic syndrome characterized by multiple cognitive deficits but not always by the presence of cognitive impairment. Cognitive impairment is associated with multiple non-modifiable risk factors but few modifiable factors. Epidemiologic studies have shown an association between periodontitis, a potentially modifiable risk factor, and cognitive impairment. The objective of this study is to determine whether clinical periodontitis is associated with the diagnosis of cognitive impairment/dementia after controlling for known risk factors, including age, sex, and education level. METHODS A case-control study was conducted in Granada, Spain, in two groups of dentate individuals aged >50 years: 1) cases with a firm diagnosis of mild cognitive impairment or dementia of any type or severity and 2) controls with no subjective memory loss complaints and a score >30 in the Phototest cognitive test (screening test for cognitive impairment). Periodontitis was evaluated by measuring tooth loss, plaque and bleeding indexes, probing depths, and clinical attachment loss (AL). RESULTS The study included 409 dentate adults, 180 with cognitive impairment and 229 without. A moderate and statistically significant association was observed between AL and cognitive impairment after controlling for age, sex, education level, oral hygiene habits, and hyperlipidemia (P = 0.049). No significant association was found between tooth loss and cognitive impairment. CONCLUSION Periodontitis appears to be associated with cognitive impairment after controlling for confounders such as age, sex, and education level.
Collapse
|
15
|
Guzman-Sanchez F, Valdivieso F, Burgos JS. Aging-Related Neurostructural, Neuropathological, and Behavioral Changes Associated with Herpes Simplex Virus Type 1 Brain Infection in Mice. ACTA ACUST UNITED AC 2012; 30:779-90. [DOI: 10.3233/jad-2012-120070] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Affiliation(s)
- Fernando Guzman-Sanchez
- Centro de Biología Molecular Severo Ochoa, Departamento de Biología Molecular, Universidad Autónoma de Madrid, Madrid, Spain
- Consejo Superior de Investigaciones Científicas (CBM-UAM-CSIC), Cantoblanco, Madrid, Spain
| | - Fernando Valdivieso
- Centro de Biología Molecular Severo Ochoa, Departamento de Biología Molecular, Universidad Autónoma de Madrid, Madrid, Spain
- Consejo Superior de Investigaciones Científicas (CBM-UAM-CSIC), Cantoblanco, Madrid, Spain
| | - Javier S. Burgos
- BioPharma Division, Neuron Bio, Parque Tecnológico de Ciencias de la Salud, Edificio BIC, Armilla, Granada, Spain
| |
Collapse
|
16
|
Abstract
This work describes a novel mechanism of neuroprotection by simvastatin: the modulation of seladin-1, an enzyme involved in Alzheimer's disease. Genomic and proteomic studies in human neuronal cells showed seladin-1 production to be increased in a dose- and time-dependent manner by simvastatin. This was confirmed in mice by immunohistochemical and qRT-PCR studies.
Collapse
Affiliation(s)
- Maria C Ramos
- Neuron BIO, BioPharma Division, Parque Tecnológico de Ciencias de la Salud, Edificio BIC, Armilla, Granada, Spain
| | | | | | | | | |
Collapse
|
17
|
Santana S, Rico EP, Burgos JS. Can zebrafish be used as animal model to study Alzheimer's disease? Am J Neurodegener Dis 2012; 1:32-48. [PMID: 23383380 PMCID: PMC3560447] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 04/16/2012] [Accepted: 05/03/2012] [Indexed: 06/01/2023]
Abstract
Zebrafish is rapidly emerging as a promising model organism to study various central nervous system (CNS) disorders, including Alzheimer's disease (AD). AD is the main cause of dementia in the human population and there is an urgency to understand the causes of this neurodegenerative disease. In this respect, the development of new animal models to study the underlying neurodegenerative mechanisms of AD is an urgent need. In this review we analyze the current situation in the use of zebrafish as a model for AD, discussing the reasons to use this experimental paradigm in CNS investigation and analyzing the several strategies adopted to induce an AD-like pathology in zebrafish. We discuss the strategies of performing interventions to cause damage in the zebrafish brain by altering the major neurotransmitter systems (such as cholinergic, glutamatergic or GABAergic circuits). We also analyze the several transgenic zebrafish constructed for the AD study, discussing both the familial-AD models based on APP processing pathway (APP and presenilins) and in the TAU hyperphosphorylation, together with the genes involved in sporadic-AD, as apolipoprotein E. We conclude that zebrafish is in a preliminary stage of development in the AD field, and that the transgenic animals must be improved to use this fish as an optimal model for AD research. Furthermore, a deeper knowledge of the zebrafish brain and a better characterization of the injury caused by alterations in the major neurotransmitter systems are needed.
Collapse
Affiliation(s)
- Soraya Santana
- BioPharma Division, Neuron Bio, Parque Tecnológico de Ciencias de la SaludEdificio BIC, Avda. de la Innovación 1, 18100 Armilla, Granada, Spain
| | - Eduardo P Rico
- Departamento de Bioquímica, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do SulRua Ramiro Barcelos 2600-Anexo, Porto Alegre, RS, Brazil
| | - Javier S Burgos
- BioPharma Division, Neuron Bio, Parque Tecnológico de Ciencias de la SaludEdificio BIC, Avda. de la Innovación 1, 18100 Armilla, Granada, Spain
| |
Collapse
|
18
|
Burgos JS, Benavides J, Douillet P, Velasco J, Valdivieso F. How statins could be evaluated successfully in clinical trials for Alzheimer's disease? Am J Alzheimers Dis Other Demen 2012; 27:151-3. [PMID: 22510498 PMCID: PMC10845673 DOI: 10.1177/1533317512442998] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Over the last decade, a large number of experimental observations have suggested a relationship between alterations in cholesterol homeostasis and Alzheimer's disease (AD). Moreover, epidemiological studies have pointed an association between statin treatment and a decrease in the risk of having AD. For these reasons, a large number of clinical trials have been carried out to determine whether the statins can prevent the progression of AD. However, these studies did not provide clear evidence for the therapeutic efficacy in AD. We consider that there are a number of explanations for this failure that may provide guidance for selecting and clinically developing statins with therapeutic efficacy in AD.
Collapse
Affiliation(s)
- Javier S Burgos
- BioPharma Division, Neuron Bio, Parque Tecnológico de Ciencias de la Salud, Armilla, Granada, Spain.
| | | | | | | | | |
Collapse
|
19
|
Sierra S, Alfaro JM, Sánchez S, Burgos JS. Administration of docosahexaenoic acid before birth and until aging decreases kainate-induced seizures in adult zebrafish. Brain Res Bull 2012; 88:467-70. [PMID: 22542883 DOI: 10.1016/j.brainresbull.2012.04.007] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2012] [Revised: 03/23/2012] [Accepted: 04/10/2012] [Indexed: 01/12/2023]
Abstract
Docosahexaeonic acid (DHA) is the final compound in the omega-3 polyunsaturated fatty acids (PUFA) synthetic pathway and the most abundant PUFA found in the brain. DHA plays an essential role in the development of the brain, and the intakes in pregnancy and early life affect growth and cognitive performance later in childhood. Recently, it has been proposed that dietary intake of DHA could be a non-pharmacological interventional strategy for the treatment of seizures in humans. However, to date, the experimental approaches to study the antiepileptic effect of DHA have been exclusively restricted to rodent models during short-to-medium periods of treatment. The purpose of the present study was to test the chronic anticonvulsivant effects of DHA supplementation in zebrafish from the pre-spawning stage to aging, taking advantage of our recently described kainate-induced seizure model using this animal. To that end, two groups of adult female zebrafish were fed with standard or 200mg/kg DHA-enriched diets during 1 month previous to the spawning, and offspring subdivided in two categories, and subsequently fed with standard or DHA diets, generating 4 groups of animals that were aged until 20 months. Afterward, KA was intraperitoneally administered and epileptic score determined. All the DHA-enriched groups presented antiepileptic effects compared to the control group, showing that DHA presents an anticonvulsant potential. Among the studied groups, zebrafish fed with DHA from the pre-spawning stage to aging presented the best antiepileptic profile. These results show a neuroprotective benefit in zebrafish fed with DHA-enriched diet before birth and during the whole life.
Collapse
Affiliation(s)
- Saleta Sierra
- Neuron Bio, BioPharma Division, Parque Tecnológico de Ciencias de la Salud, Edificio BIC, Av. Innovación 1, Armilla 18100, Granada, Spain
| | | | | | | |
Collapse
|
20
|
Ramirez C, Tercero I, Pineda A, Burgos JS. Simvastatin is the statin that most efficiently protects against kainate-induced excitotoxicity and memory impairment. J Alzheimers Dis 2012; 24:161-74. [PMID: 21224519 DOI: 10.3233/jad-2010-101653] [Citation(s) in RCA: 54] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Statins have recently been shown to act as protectants against several neuropathological conditions. They have received special attention in the field of Alzheimer's disease (AD), where epidemiological studies indicating a lower prevalence of AD/dementia in statin-prescribed populations. Excitotoxicity, which derives from the overstimulation of glutamate receptors, is a major cause of neuron death in several neurological diseases, including AD and epilepsy. We have carried out a comparative study to investigate the effects of all the commercially available statins (simvastatin, lovastatin, fluvastatin, pravastatin, and atorvastatin) on neuron damage and memory impairment. To this end, we studied neurodegeneration in a mouse model by systemic administration of kainate. Simvastatin was the most effective statin in reducing the deleterious effects caused by kainate, including the severity of seizures, excitotoxicity, oxidative damage, neuritic dystrophy and apoptosis in the hippocampus and other limbic structures of the brain cortex. Lovastatin was the second most efficient statin in preventing seizures and histopathological signs of excitotoxicity, whilst fluvastatin, pravastatin, and atorvastatin showed neither antiepileptic nor neuroprotective effects. Only simvastatin enhanced episodic-like memory. To the best of our knowledge this is the first in vivo study to analyze the neuroprotective effect of all the commercially available statins. Our results suggest that both simvastatin and lovastatin (but especially simvastatin) may well have therapeutic potential in the treatment of neurodegenerative diseases involving excitotoxicity and memory impairment, including AD.
Collapse
Affiliation(s)
- Carlos Ramirez
- NEURON BPh, BioPharma Division, Parque Tecnológico de Ciencias de Salud, Edif. BIC-Granada, Armilla, Granada, Spain
| | | | | | | |
Collapse
|
21
|
Ramírez C, Sierra S, Tercero I, Vázquez JA, Pineda A, Manrique T, Burgos JS. ApoB100/LDLR-/- hypercholesterolaemic mice as a model for mild cognitive impairment and neuronal damage. PLoS One 2011; 6:e22712. [PMID: 21829488 PMCID: PMC3144244 DOI: 10.1371/journal.pone.0022712] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2011] [Accepted: 06/28/2011] [Indexed: 11/19/2022] Open
Abstract
Recent clinical findings support the notion that the progressive deterioration of cholesterol homeostasis is a central player in Alzheimer's disease (AD). Epidemiological studies suggest that high midlife plasma total cholesterol levels are associated with an increased risk of AD. This paper reports the plasma cholesterol concentrations, cognitive performance, locomotor activity and neuropathological signs in a murine model (transgenic mice expressing apoB100 but knockout for the LDL receptor [LDLR]) of human familial hypercholesterolaemia (FH). From birth, these animals have markedly elevated LDL-cholesterol and apolipoprotein B100 (apoB100) levels. These transgenic mice were confirmed to have higher plasma cholesterol concentrations than wild-type mice, an effect potentiated by aging. Further, 3-month-old transgenic mice showed cholesterol (total and fractions) concentrations considerably higher than those of 18-month-old wild-type mice. The hypercholesterolaemia of the transgenic mice was associated with a clear locomotor deficit (as determined by rotarod, grip strength and open field testing) and impairment of the episodic-like memory (determined by the integrated memory test). This decline in locomotor activity and cognitive status was associated with neuritic dystrophy and/or the disorganization of the neuronal microtubule network, plus an increase in astrogliosis and lipid peroxidation in the brain regions associated with AD, such as the motor and lateral entorhinal cortex, the amygdaloid basal nucleus, and the hippocampus. Aortic atherosclerotic lesions were positively correlated with age, although potentiated by the transgenic genotype, while cerebral β-amyloidosis was positively correlated with genetic background rather than with age. These findings confirm hypercholesterolaemia as a key biomarker for monitoring mild cognitive impairment, and shows these transgenic mice can be used as a model for cognitive and psycho-motor decline.
Collapse
|
22
|
Sierra S, Ramos MC, Molina P, Esteo C, Vázquez JA, Burgos JS. Statins as neuroprotectants: a comparative in vitro study of lipophilicity, blood-brain-barrier penetration, lowering of brain cholesterol, and decrease of neuron cell death. J Alzheimers Dis 2011; 23:307-18. [PMID: 21098985 DOI: 10.3233/jad-2010-101179] [Citation(s) in RCA: 151] [Impact Index Per Article: 11.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
There is growing evidence to support the hypothesis that statins may act as neuroprotectants in several neuropathological conditions, including Alzheimer's disease. The mechanisms for neuroprotection are only partially understood, however, and pleiotropic phenomena could be involved. We have made a comparative study of 9 statins (lovastatin, mevastatin, pravastatin, simvastatin, cerivastatin, atorvastatin, fluvastatin, pitavastatin, and rosuvastatin), analyzing several parameters that could be related to neuroprotection, such as chemical structure, lipophilicity, potential blood-brain-barrier penetration (BBB), 3-hydroxy-3-methylglutaryl co-enzyme A reductase inhibition, cholesterol modulation in neurons, glia, and human hepatocyte cell lines, and protection against neurodegeneration caused by tau hyperphosphorylation induced by okadaic acid. Our results indicate that monacolin J derivatives (natural and semi-synthetic statins) are the best candidates for the prevention of neurodegenerative conditions due to their higher potential BBB penetration capacity, cholesterol lowering effect on neurons with a satisfactory safety profile, and in vitro protection against cell death caused by okadaic acid in culture. Among the nine statins studied, simvastatin presented the best characteristics for preventing neurodegenerative conditions.
Collapse
Affiliation(s)
- Saleta Sierra
- BioPharma Division, Neuron BPh, Parque Tecnológico de Ciencias de la Salud, Edificio BIC, Armilla, Granada, Spain
| | | | | | | | | | | |
Collapse
|
23
|
Abstract
Glutamate is the major excitatory neurotransmitter of the central nervous system in vertebrates. Excitotoxicity, caused by over-stimulation of the glutamate receptors, is a major cause of neuron death in several brain diseases, including epilepsy. We describe here how behavioural seizures can be triggered in adult zebrafish by the administration of kainate and are very similar to those observed in rodent models. Kainate induced a dose-dependent sequence of behavioural changes culminating in clonus-like convulsions. Behavioural seizures were suppressed by DNQX (6,7-dinitroquinoxaline-2,3-dione) dose-dependently, whilst MK-801 (a non-competitive NMDA receptor antagonist) had a lesser effect. Kainate triggers seizures in adult zebrafish, and thus this species can be considered as a new model for studying seizures and subsequent excitotoxic brain injury.
Collapse
Affiliation(s)
- Juan M Alfaro
- NEURON BPh, BioPharma Division, Parque Tecnológico de Ciencias de la Salud, Edif. BIC-Granada, Av. Innovación 1, Armilla 18100, Granada, Spain
| | | | | |
Collapse
|
24
|
Bonzon-Kulichenko E, Pérez-Hernández D, Núñez E, Martínez-Acedo P, Navarro P, Trevisan-Herraz M, Ramos MDC, Sierra S, Martínez-Martínez S, Ruiz-Meana M, Miró-Casas E, García-Dorado D, Redondo JM, Burgos JS, Vázquez J. A robust method for quantitative high-throughput analysis of proteomes by 18O labeling. Mol Cell Proteomics 2010; 10:M110.003335. [PMID: 20807836 DOI: 10.1074/mcp.m110.003335] [Citation(s) in RCA: 73] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023] Open
Abstract
MS-based quantitative proteomics plays an increasingly important role in biological and medical research and the development of these techniques remains one of the most important challenges in mass spectrometry. Numerous stable isotope labeling approaches have been proposed. However, and particularly in the case of (18)O-labeling, a standard protocol of general applicability is still lacking, and statistical issues associated to these methods remain to be investigated. In this work we present an improved high-throughput quantitative proteomics method based on whole proteome concentration by SDS-PAGE, optimized in-gel digestion, peptide (18)O-labeling, and separation by off-gel isoelectric focusing followed by liquid chromatography-LIT-MS. We demonstrate that the off-gel technique is fully compatible with (18)O peptide labeling in any pH range. A recently developed statistical model indicated that partial digestions and methionine oxidation do not alter protein quantification and that variances at the scan, peptide, and protein levels are stable and reproducible in a variety of proteomes of different origin. We have also analyzed the dynamic range of quantification and demonstrated the practical utility of the method by detecting expression changes in a model of activation of Jurkat T-cells. Our protocol provides a general approach to perform quantitative proteomics by (18)O-labeling in high-throughput studies, with the added value that it has a validated statistical model for the null hypothesis. To the best of our knowledge, this is the first report where a general protocol for stable isotope labeling is tested in practice using a collection of samples and analyzed at this degree of statistical detail.
Collapse
Affiliation(s)
- Elena Bonzon-Kulichenko
- Laboratory of Protein Chemistry and Proteomics, Centro de Biología Molecular Severo Ochoa (CSIC-UAM), Madrid, E-28049, Spain
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
25
|
Alfaro JM, Prades A, del Carmen Ramos M, Peris E, Ripoll-Gómez J, Poyatos M, Burgos JS. Biomedical Properties of a Series of Ruthenium-N-Heterocyclic Carbene Complexes Based on Oxidant Activity In Vitro and Assessment In Vivo of Biosafety in Zebrafish Embryos. Zebrafish 2010; 7:13-21. [DOI: 10.1089/zeb.2009.0601] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023] Open
Affiliation(s)
- Juan M. Alfaro
- BioPharma Unit, Neuron BPh, Health Science Technology Park, Armilla, Spain
| | - Amparo Prades
- Department of Inorganic and Organic Chemistry, University Jaume I, Castellón, Spain
| | | | - Eduardo Peris
- Department of Inorganic and Organic Chemistry, University Jaume I, Castellón, Spain
| | - Jorge Ripoll-Gómez
- BioPharma Unit, Neuron BPh, Health Science Technology Park, Armilla, Spain
| | - Macarena Poyatos
- Department of Inorganic and Organic Chemistry, University Jaume I, Castellón, Spain
| | - Javier S. Burgos
- BioPharma Unit, Neuron BPh, Health Science Technology Park, Armilla, Spain
| |
Collapse
|
26
|
Abstract
The zebrafish (Danio rerio) is rapidly gaining ground as a disease model. However, until now, the use of this species with human pathogens has been restricted to just three bacteria; no studies involving viruses that infect humans are recorded. In this study, the zebrafish was used as a model of herpes simplex virus type 1 (HSV-1) infection of the nervous system. Fish infected using viral culture supernatants showed detectable HSV-1 DNA concentrations 1-4 days after inoculation, indicating that this virus can experimentally infect and persist in this host. The kinetics of infection was dose dependent, especially in the head. Histological immunodetection of HSV-1 glycoproteins confirmed the presence of HSV-1 in the organs studied; infection led to histopathological changes. Moreover, the suppression of the immune system by cyclophosphamide and the antiviral effect of acyclovir were demonstrated. The infection of the encephalon was studied in detail, and the time course of viral colonization recorded. Immunofluorescence studies provided immunoreactive evidence of viral antigens in the encephalon and spinal cord. Viruses cleared from infected brains showed the ability to infect human neuroblastoma cells. This study is the first to demonstrate HSV-1 infection in the zebrafish and manifests the potential use of this species in herpesvirus studies.
Collapse
Affiliation(s)
- Javier S Burgos
- Drug Discovery Unit, NEURON BioPharma , Edificio BIC, Avda. Innovación 1, Armilla, Spain.
| | | | | | | | | |
Collapse
|
27
|
Abstract
Traditional studies of viral and bacterial infection and pathogenesis have generally relied on animal models that require the sacrifice of infected animals to determine viral or bacterial distributions and titers. The recent application of the in vivo bioluminescence imaging (BLI) to monitor the replication and tropism of pathogens expressing the luciferase (from firefly or Renilla) reporter proteins has been recently developed. This technology do not requires the sacrifice of the experimental animals, where the in vivo bioluminescence emissions in living animals permit the tracking of the infection. It has been demonstrated that the in vivo BLI is comparable to the classical approaches as measurements of in vitro light emission in organs of sacrificed animals. Moreover, molecular techniques such as PCR determinations show parallel results in pathogen quantification, where the concentrations of microbial DNA measured correlated with the magnitude of bioluminescence in vivo, and with the photon flux determined by the in vitro luciferase enzyme assay. These results show that BLI can be used for noninvasive, real-time monitoring of several infections of pathogens in living animals, supplying a new methodology in the study of pathogens in addition to conventional techniques for the characterization of infections.
Collapse
|
28
|
Burgos JS, Ramirez C, Sastre I, Valdivieso F. Apolipoprotein E genotype influences vertical transmission of herpes simplex virus type 1 in a gender specific manner. Aging Cell 2007; 6:841-2. [PMID: 17725689 DOI: 10.1111/j.1474-9726.2007.00332.x] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
Abstract
There is growing evidence that herpes simplex virus type 1 (HSV-1), together with the apolipoprotein E 4 (APOE4) allele, contribute to the pathogenesis of Alzheimer's disease (AD), although the mechanism of their interaction remains uncertain. Here we show that the combination of inherited APOE genotype and vertical transmission of HSV-1 confers a differential risk of brain infection. These risk factors are known to be associated with AD.
Collapse
Affiliation(s)
- Javier S Burgos
- NEURON BioPharma, Drug Discovery Unit, Edificio BIC, Armilla, Granada, Spain.
| | | | | | | |
Collapse
|
29
|
Abstract
Herpes simplex virus type 1 (HSV-1) is neurotropic and enters a latent state lasting the lifetime of the host. This pathogen has recently been proposed as a risk factor for Alzheimer's disease (AD) in conjunction with apolipoprotein E4 (ApoE4). In a murine acute infection model, we showed that viral neuroinvasiveness depends directly on the overall ApoE dosage and especially on the presence of isoform ApoE4. If an interaction between ApoE and HSV-1 is involved in AD, it may occur during latency rather than during acute infection. Certainly, ApoE plays an important role in late-onset AD, i.e., at a time in life when the majority of people harbor HSV-1 in their nervous system. In the present work, wild-type, APOE knockout, APOE3, and APOE4 transgenic mice were used to analyze the influence of the ApoE profile on the levels of latent virus DNA. The knockout mice had significantly lower concentrations of the virus in the nervous system than the wild-type mice, while the APOE4 mice had very high levels in the brain compared to the APOE3 animals. ApoE4 seems to facilitate HSV-1 latency in the brain much more so than ApoE3. The APOE dosage correlated directly with the HSV-1 DNA concentration in the brain, strengthening the hypothesis that HSV-1, together with ApoE, might be involved in AD.
Collapse
Affiliation(s)
- Javier S Burgos
- Lab CX340, Centro de Biología Molecular, Universidad Autónoma de Madrid, Cantoblanco, 28049 Madrid, Spain.
| | | | | | | |
Collapse
|
30
|
Abstract
Evaluation of: Miller RM, Federoff HJ: Isoform-specific effects of ApoE on HSV immediate early gene expression and establishment of latency. Neurobiol. Aging (2006) (Epub ahead of print). It is 100 years since Alzheimer's disease was first described and there is still no consensus of opinion regarding the etiology of its sporadic form. Herpes simplex virus type 1 (HSV-1), in conjunction with apolipoprotein E (ApoE), may well play a role in this form of the disease. In the evaluated article, Miller and Federoff try to determine whether the ApoE profile affects the expression of the HSV-1 immediate-early genes and the production of the virus’ latency-associated transcript. Their results show that overexpression of the intermediate-early genes and the establishment of latency are directly correlated with the ApoE genotype.
Collapse
Affiliation(s)
- Javier S Burgos
- NEURON BioPharma, Drug Discovery Unit, Edificio BIC, Avda, Innovación 1, 18100 Armilla, Granada, Spain
| | - Fernando Valdivieso
- Universidad Autónoma de Madrid, Centro de Biología Molecular Severo Ochoa, Departamento de Biologí Molecular Facultad de Ciencias, Lab CX340, 18049 Cantoblanco, Madrid, Spain
| |
Collapse
|
31
|
Burgos JS, Serrano-Saiz E, Sastre I, Valdivieso F. ICP47 mediates viral neuroinvasiveness by induction of TAP protein following intravenous inoculation of herpes simplex virus type 1 in mice. J Neurovirol 2007; 12:420-7. [PMID: 17162658 DOI: 10.1080/13550280601009546] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
Herpes simplex virus type 1 (HSV-1) expresses an immediate-early protein, ICP47, that blocks the major histocompatibility complex class I antigen presentation pathway by binding to the transporter associated with antigen presentation (TAP). The result is the virus' evasion of the immune system. Although the interaction between ICP47 and TAP has been examined in vitro, this paper is the first to report their interaction in vivo. In C57BL/6 adult female mice, ICP47-defective virus (Delta ICP47, F strain) was less able to invade the organs studied than was wild-type HSV-1 F strain, showing that ICP47 influences general invasiveness. However, the neuroinvasiveness of the Delta ICP47 virus was recovered in TAP-deficient mice, indicating that the TAP-ICP47 interaction is specific to neural tissues. HSV-1 F strain showed no significant differences in their invasiveness in TAP-deficient and wild-type mice. Therefore, although ICP47 appears to be essential for invasion, the presence of TAP appears not to be crucial. Western blotting showed TAP1 expression to increase by at least fourfold in the brains and adrenal glands of infected mice. This suggests that TAP plays an important role in the host defense system. This increased expression may be particularly important in the encephalon since the baseline protein levels of this organ are low (ratio adrenal protein level/encephalon protein level > 100). However, Delta ICP47 virus provoked no significant increase in the brain TAP1 levels of wild-type mice because it could not invade this organ. These results suggest that ICP47 plays a role in infection, and that TAP1 production is regulated during viral challenge.
Collapse
Affiliation(s)
- Javier S Burgos
- Departamento de Biología Molecular and Centro de Biologí Molecular Severo Ochoa, C.S.I.C.-U.A.M., Universidad Autónoma de Madrid, Madrid, Spain.
| | | | | | | |
Collapse
|
32
|
Burgos JS, Ramirez C, Brachet A, Alfaro JM, Sastre I, Valdivieso F. Changes in immunoglobulin levels related to herpes simplex virus type 1 brain infection in pregnant mice. J Neurovirol 2007; 13:233-41. [PMID: 17613713 DOI: 10.1080/13550280701308467] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
Disseminated herpes simplex virus type 1 (HSV-1) infection during pregnancy is poorly described even though it is associated with high maternal and fetal morbidity and neonatal mortality in humans. In a previous paper using mice as a model, the authors demonstrated that HSV-1 is transmitted hematogenously from mother to offspring, the virus colonizing the central nervous system and provoking high mortality. In the present study, viral DNA levels in latently infected mothers were investigated during pregnancy and after delivery in mice. Samples from different organs were obtained before gestation (latency), three times during pregnancy (17, 4.5, and 1 day before delivery), and four times after delivery (1 day, 1 week, 1 and 2 months). A dramatic decrease in viral DNA concentration was observed during pregnancy, especially in the nervous system, with postnatal recovery to latent levels. All the brain regions studied showed similar trends. The viral copy numbers detected in mothers at delivery +1 day were independent of viral inoculum size. The spread of the virus to the above organs was examined immunohistochemically and, in general, more intense viral staining was observed after delivery in each. Because immunoglobulin levels can be modified by infections during pregnancy, the authors examined the levels of specific HSV-1 antibodies. Variation in HSV-1 DNA concentration was found to be associated with changes in the full spectrum of immunoglobulins (but especially immunoglobulin M [IgM]) over pregnancy, whereas at delivery -1 day a significant inverse relationship between immunoglobulins and HSV-1 DNA was observed. IgGs provided protection during the postnatal phase.
Collapse
MESH Headings
- Animals
- Animals, Newborn
- Antibodies, Viral/blood
- DNA, Viral/metabolism
- Disease Models, Animal
- Encephalitis, Herpes Simplex/immunology
- Encephalitis, Herpes Simplex/pathology
- Female
- Herpes Simplex/immunology
- Herpes Simplex/pathology
- Herpesvirus 1, Human/genetics
- Herpesvirus 1, Human/immunology
- Immunoglobulin A/metabolism
- Immunoglobulin G/metabolism
- Immunoglobulin M/metabolism
- Mice
- Pregnancy
- Pregnancy Complications, Infectious/immunology
- Pregnancy Complications, Infectious/pathology
- Pregnancy Complications, Infectious/virology
Collapse
Affiliation(s)
- Javier S Burgos
- Departamento de Biología Molecular and Centro de Biología Molecular Severo Ochoa (C.S.I.C.-U.A.M.), Universidad Autónoma de Madrid, Spain.
| | | | | | | | | | | |
Collapse
|
33
|
Burgos JS, Guzman-Sanchez F, Sastre I, Fillat C, Valdivieso F. Non-invasive bioluminescence imaging for monitoring herpes simplex virus type 1 hematogenous infection. Microbes Infect 2006; 8:1330-8. [PMID: 16682243 DOI: 10.1016/j.micinf.2005.12.021] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2005] [Revised: 12/22/2005] [Accepted: 12/26/2005] [Indexed: 11/25/2022]
Abstract
Traditional studies on viral neuroinvasiveness and pathogenesis have generally relied on murine models that require the sacrifice of infected animals to determine viral distributions and titers. The present paper reports the use of in vivo bioluminescence imaging to monitor the replication and tropism of KOS strain HSV-1 viruses expressing the firefly luciferase reporter protein in hematogenously infected mice. Following intraperitoneal injection, a comparison was made between real-time PCR determinations of HSV-1 DNA concentrations (requiring the sacrifice of the experimental animals) and in vivo bioluminescence emissions in living animals. For further comparison, in vitro light emission was also measured in the ovaries and adrenal glands of sacrificed mice. After infection, HSV-1 spread preferentially to the ovaries and adrenal glands (these organs showed the highest virus levels). Both the PCR and bioluminescence methods detected low viral loads in the nervous system, where the virus was restricted to the spinal cord. The concentrations of viral DNA measured correlated with the magnitude of bioluminescence in vivo, and with the photon flux determined by the in vitro luciferase enzyme assay. The results show that bioluminescence imaging can be used for non-invasive, real-time monitoring of HSV-1 hematogenous infection in living mice, but that coupling this methodology with conventional techniques aids in the characterization of the infection.
Collapse
Affiliation(s)
- Javier S Burgos
- Departamento de Biología Molecular and Centro de Biología Molecular Severo Ochoa (C.S.I.C.-U.A.M.), Universidad Autónoma de Madrid, Spain.
| | | | | | | | | |
Collapse
|
34
|
Burgos JS, Ramirez C, Guzman-Sanchez F, Alfaro JM, Sastre I, Valdivieso F. Hematogenous vertical transmission of herpes simplex virus type 1 in mice. J Virol 2006; 80:2823-31. [PMID: 16501091 PMCID: PMC1395468 DOI: 10.1128/jvi.80.6.2823-2831.2006] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2005] [Accepted: 12/22/2005] [Indexed: 11/20/2022] Open
Abstract
Herpes simplex virus type 1 (HSV-1) is a neurotropic virus that causes severe disease and death in newborn humans but, to date, it remains unclear how neonatal infection occurs. We show here that the vertical transmission of HSV-1 in mice is mainly hematogenous and involves the colonization of the neonate central nervous system (CNS). HSV-1 DNA was mainly detected in the blood and CNS of the offspring born to latently infected mothers; no significant differences were seen between the viral DNA concentrations in the blood of these mothers and their female progeny (either neonate or adult). The administration of acyclovir during gestation reduced or eliminated both the maternal and the neonatal viral DNA in the blood. Embryo transfer was performed to ensure (as far as possible) that only vertical hematogenous infection took place. Immunohistochemical analysis detected viral proteins in the encephalon of the offspring. Immunofluorescence studies provided immunoreactive evidence of HSV-1 proteins in the neurons of the hippocampus and showed that these viruses can molecularly reactivate after hyperthermia. Neonatal HSV-1 infection therefore appears to be mainly caused by hematogenous vertical transmission, and the viruses that colonize the offspring CNS are capable of molecular reactivation after a period of latency.
Collapse
Affiliation(s)
- Javier S Burgos
- Departamento de Biología Molecular and Centro de Biología Molecular, Universidad Autónoma de Madrid, 28049 Cantoblanco, Madrid, Spain
| | | | | | | | | | | |
Collapse
|
35
|
Burgos JS, Ramirez C, Sastre I, Alfaro JM, Valdivieso F. Herpes simplex virus type 1 infection via the bloodstream with apolipoprotein E dependence in the gonads is influenced by gender. J Virol 2005; 79:1605-12. [PMID: 15650186 PMCID: PMC544102 DOI: 10.1128/jvi.79.3.1605-1612.2005] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Herpes simplex virus type 1 (HSV-1) causes disease in humans and animals. Infection usually occurs via the neural route and possibly occurs via the hematogenous route. The latter, however, is the main route by which immunosuppressed individuals and neonates are infected. Gender-dependent differences in the incidence and severity of some viral infections have been reported. To detect differences between the sexes with respect to HSV-1 colonization and disease, the characteristics of both acute and latent infections in hematogenously infected male and female mice were compared. In acute infection, the female mice had a poorer outcome: HSV-1 colonization was more effective, especially in the gonads and brain. In the encephalon, the midbrain had the highest viral load. In latent infection, brain viral loads were not significantly different with respect to sex. Significant differences were seen, however, in the blood and trigeminal ganglia: HSV-1 seroprevalence was observed in females, with no virus detected in males. In brain dissections, only the cerebral cortex of the females had viral loads statistically higher than those observed in the males. The spread of the virus to several organs of interest during acute infection was examined immunohistochemically. Female mice showed greater viral immunostaining, especially in the adrenal cortex, gonads, and midbrain. In male mice, HSV-1 was detected predominantly in the adrenal cortex. It was also found that apolipoprotein E promotes virus colonization of the ovaries, the APOE gene dose being directly related to viral invasiveness.
Collapse
Affiliation(s)
- Javier S Burgos
- Departamento de Biología Molecular, Facultad de Ciencias, Universidad Autónoma de Madrid, Lab CX340, Cantoblanco, 28049 Madrid, Spain.
| | | | | | | | | |
Collapse
|
36
|
Abstract
The aim of this study was to discuss the relevance of the Epstein-Barr virus (EBV) in the nasopharyngeal carcinoma (NPC), analyzing the variations of several molecules potentially involved in the pathogenesis of this cancer. EBV was detected in all the NPC samples by several techniques including PCR, in situ hybridization, and immunohistochemical methodologies. CD21 membrane receptor was absent after EBV infection, being a differential morphological feature of the tumoral cells. Latent membrane protein-1 (LMP1), an oncogenic viral product, was detected in a high percentage of samples, supporting a role for EBV in the pathogenesis of NPC. Bcl-2, an anti-apoptotic protein up-regulated by LMP1, was also overexpressed, coinciding with the majority of samples positive for LMP1. Finally, p53 presented abnormalities only in a low percentage of samples. These results reinforce the role of the EBV in the NPC discussing several potential mechanisms of pathogenesis in this neoplasia.
Collapse
Affiliation(s)
- Javier S Burgos
- Centro de Biología Molecular Severo Ochoa - C.S.I.C., Universidad Autónoma de Madrid, Cantoblanco, Madrid, Spain.
| |
Collapse
|
37
|
Abstract
The objective of this study was to analyse the relationships between the Epstein-Barr virus (EBV) infection and the molecular abnormalities of the p53 oncoprotein in the nasopharyngeal carcinoma (NPC). Fifty-five NPC paraffin samples from a group of Spanish patients with EBV demonstrated presence by nested-PCR and non-isotopic in situ hybridisation, were analysed for p53 expression using immunohistochemistry. The positive samples by immunohistochemistry were studied for p53 gene alterations in the exon 5 by single strand conformation polymorphism (SSCP). Among the 55 specimens, 14 (25.5%) showed expression of p53 protein. All these positive samples corresponded to the late stage of the tumour. Of the 14 samples, p53 gene alterations were found only in three cases using SSCP. These results indicate that the p53 mutations are an infrequent event in NPC in Spanish patients needing exogenous factors as the EBV infection for the development of this malignancy.
Collapse
Affiliation(s)
- Javier S Burgos
- Centro de Biología Molecular Severo Ochoa--C.S.I.C., Universidad Autónoma de Madrid, Cantoblanco, Madrid, Spain.
| |
Collapse
|
38
|
Abstract
Apolipoprotein E (ApoE) plays a relevant role in herpes simplex type 1 (HSV-1) infection of the CNS; after infection by the hematogenous route, the viral neuroinvasiveness directly depends on the APOE gene dose. To analyze the effect of ApoE isoforms on the HSV-1 infectivity to the brain, we have used a model of hematogenous infection of mice humanized for the ApoE3 or the ApoE4 alleles, and we have analyzed the presence of viral DNA in several organs by real time quantitative PCR. We have found that animals expressing human ApoE4 present very high levels of virus in the brain when compared to those expressing the ApoE3 allele; in contrast, there were no significant differences in the viral levels found in peripheral organs. Apolipoprotein E4 seems to facilitate the entry and/or spread of HSV-1 in the brain much more efficiently than E3, pointing to a novel potential mechanism underlying the susceptibility to neurodegenerative processes associated with the ApoE4 allele.
Collapse
Affiliation(s)
- Javier S Burgos
- Departamento de Biología Molecular and Centro de Biología Molecular Severo Ochoa (CSIC-UAM), Universidad Autónoma de Madrid, Madrid, Spain
| | | | | | | | | |
Collapse
|
39
|
Burgos JS, Aleu J, Barat A, Solsona C, Marsal J, Ramírez G. Kainate-triggered currents in Xenopus oocytes injected with chick retinal membrane fragments: effect of guanine nucleotides. Invest Ophthalmol Vis Sci 2003; 44:3124-9. [PMID: 12824261 DOI: 10.1167/iovs.02-0669] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
Abstract
PURPOSE To electrophysiologically characterize alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA)/kainate receptors in chick retinal membrane fragments, incorporated into Xenopus oocytes by direct microinjection. METHODS A 6-day retinal membrane suspension was injected into Xenopus oocytes by use of an electronic nanoliter injector. Fifteen to 40 hours after injection, the oocytes were assayed for kainate-elicited inward currents, under voltage-clamp conditions (membrane potential held at -70 mV). The structural incorporation of the retinal membrane fragments into the oocyte membrane was verified by specific immunofluorescent staining. RESULTS Chick retinal membrane fragments were efficiently grafted onto Xenopus oocytes after microinjection, with 22.9% +/- 7.6% of the oocyte membrane being stained with anti-chick retina antibody. Part of the retinal material was seen as patches of relatively uniform size (292.1 +/- 72.3 microm(2)). Bath-applied kainate induced dose-dependent (EC(50): 64 +/- 7 microM), nondesensitizing inward currents (15-90 nA) in the chimeric Xenopus oocytes. Sham-injected oocytes did not respond to kainate. Kainate-driven currents were blocked by 6,7-dinitroquinoxaline-2,3-dione (DNQX) and 1-(4-aminopropyl)-4-methyl-7,8-methylenedioxy-5H-2,3-benzodiazepine hydrochloride (GYKI 52466), but not by gamma-D-glutamylaminomethyl sulfonic acid (GAMS) or aminophosphonoheptanoate (AP7), suggesting the involvement of AMPA receptors in the observed responses. Guanine nucleotides (GNs) also blocked kainate currents in a concentration-dependent manner. CONCLUSIONS An alternative oocyte microinjection technique to analyze the electrophysiological properties of glutamate receptors in chick retinal membranes is described. The results show the functional activity of putative AMPA-preferring receptors from chick retina and confirm, in the chick retinal model, the antagonistic behavior of guanine nucleotides toward glutamate receptors and their potential role as neuroprotective agents under excitotoxic conditions.
Collapse
Affiliation(s)
- Javier S Burgos
- Center for Molecular Biology (CSIC-UAM), Autonomous University of Madrid, Madrid, Spain
| | | | | | | | | | | |
Collapse
|
40
|
Burgos JS, Rosol M, Moats RA, Khankaldyyan V, Kohn DB, Nelson MD, Laug WE. Time course of bioluminescent signal in orthotopic and heterotopic brain tumors in nude mice. Biotechniques 2003; 34:1184-8. [PMID: 12813886 DOI: 10.2144/03346st01] [Citation(s) in RCA: 90] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
In vivo bioluminescence imaging is becoming increasingly popular. Quantification of bioluminescence signals requires knowledge of the variability and reproducibility of this technique. The objective of this study was to analyze the time course of luminescent signal emitted from firefly luciferase-expressing tumors in two locations, following luciferin injection and at different times after tumor cell implantation. Knowledge of the kinetics of the bioluminescent signals is required for the reliable quantification and comparison of signal during longitudinal studies. The kinetics of bioluminescence was evaluated in orthotopic and heterotopic brain tumors in mice using a human brain tumor cell line constitutively expressing luciferase. Tumor cells were implanted in the brains and flanks of the animals, and whole-body images revealing tumor location were obtained. Tumor burden was monitored over time by the quantitation of photon emission. The magnitude of bioluminescence measured in vivo varied with time after the injection of luciferin, as well as with dose, which necessitated that the comparison of the quantitative results take into consideration the time after injection. Heterotopic and orthotopic tumors exhibited significantly different time courses; however, time after implantation as characterized by kinetic studies performed on days 4 and 14 after cell implantation revealed no significant differences in orthotopic tumors. Future quantitative longitudinal studies must take into account the differences in the kinetics of different models.
Collapse
Affiliation(s)
- J S Burgos
- Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA, USA
| | | | | | | | | | | | | |
Collapse
|
41
|
Burgos JS, Ramirez C, Sastre I, Bullido MJ, Valdivieso F. Involvement of apolipoprotein E in the hematogenous route of herpes simplex virus type 1 to the central nervous system. J Virol 2002; 76:12394-8. [PMID: 12414984 PMCID: PMC136918 DOI: 10.1128/jvi.76.23.12394-12398.2002] [Citation(s) in RCA: 42] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Apolipoprotein E (ApoE), a constituent of the lipoproteins, may be relevant in herpes simplex virus type 1 (HSV-1) infection of the central nervous system (CNS), since HSV-1 binds to human serum ApoE lipoproteins. This study demonstrates the involvement of ApoE in the hematogenous route of HSV-1 to the CNS.
Collapse
Affiliation(s)
- Javier S Burgos
- Departamento de Biología Molecular and Centro de Biología Molecular Severo Ochoa (C.S.I.C.-U.A.M.), Universidad Autónoma de Madrid, Cantoblanco, 28049 Madrid, Spain
| | | | | | | | | |
Collapse
|
42
|
Rubio L, Burgos JS, Lopez-Guerrero JA, Morera C, Vera-Sempere FJ. Expression of p53 protein and tumor angiogenesis as prognostic factors in nasopharyngeal carcinoma patients. Pathol Res Pract 2002; 198:97-102. [PMID: 11928871 DOI: 10.1078/0344-0338-00193] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
Abstract
The objective of this study was to evaluate the possible prognostic significance of p53 protein overexpression and tumor angiogenesis (TA) in nasopharyngeal carcinoma (NPC) patients, together with other clinicopathological variables. Forty-two NPC patients were evaluated in relation to survival. Nuclear p53 overexpression in neoplastic and endothelial cells was detected by immunohistochemistry (IHC) with the monoclonal antibody DO-7 and the polyclonal antibody against factor VIII-related antigen, respectively. Thereafter, we evaluated p53 cases in order to determine their nuclear immunoreactivity from negative (-) to positive (+, ++, +++). In addition, microvessels were counted in the most active areas of tumor neovascularization or hotspots using an image computer analyzer (MicroImage). A Cox multiple regression survival analysis was used to determine the best prognostic indicators in NPC patients. As a result, tumor microvessel count, considered as a continuous variable, was the most important independent prognostic indicator in relation to survival (p = 0.0273), with a relative risk of death of 2,4399 [95% confidence interval = 1.1051 ; 5.3871] associated with the highest microvessel counts. Moreover, the only clinicopathological variable that demonstrated prognostic value in a Cox multiple regression survival analysis was histological type (p = 0.05). In addition, we did not observe any statistical association between intratumoral microvessel density (IMD), clinicopathological variables and p53 protein expression.
Collapse
Affiliation(s)
- L Rubio
- Service of Pathology II, University Hospital La Fe, Medical School of Valencia University, Spain
| | | | | | | | | |
Collapse
|
43
|
Abstract
Real-time polymerase chain reaction (PCR) techniques are increasingly used to quantify target sequences for diagnostic and research purposes. Due to its 'quantitative' character, it is very important to determine the variability of this technique correlating with several experimental conditions. The objective of this study was to analyse the effect of manufacturing lots of PCR reagents on two main PCR parameters, specificity and sensitivity. For this study, we used four different amplicons, using either mouse genomic DNA or viral DNA. Although a PCR product could be obtained in any of the conditions, we observed that there are relevant variations in sensitivity depending on the reagents formulation. We conclude that different lots of reagents may determine the analytical performance of PCR assays indicating that reagents testing are of special importance when the PCR protocol is used for quantitative purposes.
Collapse
Affiliation(s)
- J S Burgos
- Centro de Biología Molecular Severo Ochoa - CSIC Universidad Autónoma de Madrid, Cantoblanco, Madrid, Spain.
| | | | | | | | | |
Collapse
|
44
|
Burgos JS, Vera-Sempere FJ. Analysis of EBV latency by EBER in situ hybridization in nasopharyngeal carcinoma Spanish patients. Anticancer Res 2001; 21:3921-4. [PMID: 11911270] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/24/2023]
Abstract
BACKGROUND The aim of this study was to analyse the Epstein-Barr virus (EBV) latency by detecting the EBV-associated latent small nuclear RNAs (EBER), in a group of biopsies from Spanish patients with diagnosed nasopharyngeal carcinoma (NPC). MATERIALS AND METHODS NPC paraffin samples with the presence of EBV demonstrated by non-isotopic in situ hybridization (NISH) and nested-PCR, were analysed for EBV latency using EBER in situ hybridization (EBER-ISH). RESULTS We detected EBER in 83.3% of samples (10 out of 12 cases), demonstrating the relationships between EBV genome presence with the latent viral infection. We correlated these results of EBV-DNA and -RNA presence with the immunoexpression of latent membrane protein-1 (LMP-1), a viral oncogenic protein (8 out of 12 cases or 66.6%). CONCLUSION These results indicate that all the types of NPC are variants of an EBV-associated malignancy and that viral latency is a critical phenomenon in the development of this neoplasia.
Collapse
Affiliation(s)
- J S Burgos
- Centro de Biología Molecular Severo Ochoa-C.S.I.C., Facultad de Ciencias, Universidad Autónoma de Madrid, Cantoblanco, Spain.
| | | |
Collapse
|
45
|
Lara DR, Schmidt AP, Frizzo ME, Burgos JS, Ramírez G, Souza DO. Effect of orally administered guanosine on seizures and death induced by glutamatergic agents. Brain Res 2001; 912:176-80. [PMID: 11532434 DOI: 10.1016/s0006-8993(01)02734-2] [Citation(s) in RCA: 82] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
Intraperitoneal guanosine has been shown to prevent quinolinic acid-induced seizures in mice. In this study, we investigated the effect of orally administered guanosine on seizures induced by the glutamate agonists quinolinic acid and kainate, and the endogenous glutamate releaser alpha-dendrotoxin. Guanosine (7.5 mg/kg, per os), administered 75 min in advance, prevented 70% of seizures induced by i.c.v. quinolinic acid, being as efficient as the NMDA channel blocker MK-801 administered intraperitoneally. Guanosine was ineffective against kainate-induced seizures, but significantly reversed the potentiation of seizures and death caused by the concomitant injection of MK-801. Guanosine also significantly prevented seizures and death induced by i.c.v. alpha-dendrotoxin, whereas MK-801 and phenobarbital only prevented death. Altogether, our findings underscore the therapeutic potential of oral administration of guanosine for treating diseases involving glutamatergic excitotoxicity, including epilepsy.
Collapse
Affiliation(s)
- D R Lara
- Department of Biochemistry, ICBS, Federal University of Rio Grande do Sul, Avenida Ramiro Barcelos, 2600-Anexo, CEP 90035-003, RS, Porto Alegre, Brazil
| | | | | | | | | | | |
Collapse
|
46
|
Abstract
The aim of this study was to determine the possible prognostic significance of tumor angiogenesis (TA) in nasopharyngeal carcinoma (NPC) patients. Fifty-five NPC patients were evaluated in relation to survival. Endothelial cells were immunohistochemically stained with anti-von Willebrand factor (F-VIII), CD-31 and CD-34 antibodies, and microvessels counted in the most active areas of tumor neovascularization or hotspotsusing both a manual and an automatic method. Overall survival analysis calculated by the Kaplan Meiertest revealed that both methods were correlated with a statistical significance between intratumoral microvessel density (IMD) and overall survival, using either manual (p=0.0141) or automatic counting (p=0.0117). Other angiogenic parameters studied were perimeter, roundness and accumulative area of the microvessels using a morphometric analyzer. Moreover, our results show that cases with high IMD demonstrated a prognostic significance in relation to the accumulative area (p=0.0072).
Collapse
MESH Headings
- Adult
- Antigens, CD34/analysis
- Carcinoma, Squamous Cell/blood supply
- Carcinoma, Squamous Cell/chemistry
- Carcinoma, Squamous Cell/mortality
- Endothelium, Vascular/metabolism
- Endothelium, Vascular/pathology
- Female
- Fluorescent Antibody Technique, Indirect
- Humans
- Image Processing, Computer-Assisted
- Immunoenzyme Techniques
- Male
- Microcirculation
- Middle Aged
- Nasopharyngeal Neoplasms/blood supply
- Nasopharyngeal Neoplasms/chemistry
- Nasopharyngeal Neoplasms/mortality
- Neovascularization, Pathologic/metabolism
- Neovascularization, Pathologic/pathology
- Platelet Endothelial Cell Adhesion Molecule-1/analysis
- Prognosis
- Retrospective Studies
- Survival Analysis
- Survival Rate
- von Willebrand Factor/analysis
Collapse
Affiliation(s)
- L Rubio
- Medical School of Valencia University, Service of Pathology II, University Hospital La Fe Avda. Campanar 21, Valencia, Spain
| | | | | | | |
Collapse
|
47
|
Rubio L, Burgos JS, Morera C, Vera-Sempere FJ. Morphometric study of tumor angiogenesis as a new prognostic factor in nasopharyngeal carcinoma patients. Pathol Oncol Res 2000. [PMID: 11033462 DOI: 10.1053/paor.2000.0266] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
The aim of this study was to determine the possible prognostic significance of tumor angiogenesis (TA) in nasopharyngeal carcinoma (NPC) patients. Fifty-five NPC patients were evaluated in relation to survival. Endothelial cells were immunohistochemically stained with anti-von Willebrand factor (F-VIII), CD-31 and CD-34 antibodies, and microvessels counted in the most active areas of tumor neovascularization or hotspotsusing both a manual and an automatic method. Overall survival analysis calculated by the Kaplan Meiertest revealed that both methods were correlated with a statistical significance between intratumoral microvessel density (IMD) and overall survival, using either manual (p=0.0141) or automatic counting (p=0.0117). Other angiogenic parameters studied were perimeter, roundness and accumulative area of the microvessels using a morphometric analyzer. Moreover, our results show that cases with high IMD demonstrated a prognostic significance in relation to the accumulative area (p=0.0072).
Collapse
Affiliation(s)
- L Rubio
- Medical School of Valencia University, Service of Pathology II, University Hospital La Fe Avda. Campanar 21, Valencia, Spain
| | | | | | | |
Collapse
|
48
|
Burgos JS, Vera-Sempere FJ. Immunohistochemical absence of CD21 membrane receptor in nasopharyngeal carcinoma cells infected by Epstein-Barr virus in Spanish patients. Laryngoscope 2000; 110:2081-4. [PMID: 11129025 DOI: 10.1097/00005537-200012000-00020] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
OBJECTIVES/HYPOTHESIS The aim of this study was to analyze the relevance of the CD21 membrane receptor in nasopharyngeal carcinoma (NPC). CD21 is implicated in the introduction of the Epstein-Barr virus (EBV) genome into epithelial cells and B lymphocytes. STUDY DESIGN Immunohistochemical analysis of CD21 in NPC. METHODS Paraffin-embedded samples of NPC of different histological types with demonstrated presence of EBV were analyzed for CD21 expression using immunohistochemistry. RESULTS We detected EBV by non-isotopic in situ hybridization (NISH) and nested polymerase chain reaction (PCR) in 100% of samples, regardless of histological type, supporting the previous view that all the types of NPC are variants of an EBV-associated malignancy. CD21 was not detected in NPC, and this absence was a typical feature in our data group. CONCLUSIONS The loss of the CD21 membrane receptor could be one of the immunophenotypical changes of the neoplastic cells that occur in the evolution of the NPC malignancy.
Collapse
Affiliation(s)
- J S Burgos
- Centro de Biología Molecular Severo Ochoa CSIC, Universidad Autónoma de Madrid, Cantoblanco, Spain
| | | |
Collapse
|
49
|
Abstract
The aim of this study was to show that Cl(-)-dependent excitotoxicity, with its characteristic cell swelling, involves actual water influx into the intracellular compartment. Taking advantage of the Ca2+ omission paradigm of Cl(-)-dependent excitotoxicity, in the chick embryonic neural retina ex vivo, which is associated with toxicity levels (lactate dehydrogenase (LDH) release) considerably higher than those seen after simple exposure of the retinas to glutamate agonists, we have demonstrated that an intracellular water intake of 4.2 microl into retinal cells is associated with 13.3% total retinal LDH release. The fact that mannitol blocks both water inflow and LDH release appears to link both events from a pathogenic point of view.
Collapse
Affiliation(s)
- J S Burgos
- Centro de Biologia Molecular (CSIC-UAM), Universidad Autónoma de Madrid, Spain
| | | | | |
Collapse
|
50
|
Abstract
The chick embryonic neural retina ex vivo has been singled out as a unique example of Cl(-)-dependent/Ca2+-independent excitotoxicity. However, after continuous incubation with 100 microM kainate, we have demonstrated the susceptibility of the chick retina to Ca2+-mediated damage, which becomes apparent after 12 h of exposure to the agonist in the absence of Cl-. Of the 20.8% lactate dehydrogenase released after 24 h incubation with kainate, some 11% is Cl(-)-dependent and the rest (9.8%) is presumably Ca2+-dependent. Upon omission of both Cl- and Ca2+, a 5% residual toxicity can still be detected after 24 h. This can be overcome by inclusion of EGTA in the incubation medium to neutralize Ca2+ released during incubation. A Ca2+-dependent toxicity mechanism is then operative in the embryonic chick retina ex vivo.
Collapse
Affiliation(s)
- J S Burgos
- Centro de Biologia Molecular (CSIC-UAM), Universidad Autónoma de Madrid, Spain
| | | | | |
Collapse
|